Stock listing
DNLI Stock Price, News, Filings & Events — Denali Therapeutics Inc.
Selected listing: DNLI · BX · CHF · CH
This page tracks Denali Therapeutics Inc.'s DNLI:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DNLI:BX. DNLI:BX is the stock-level entry point for investors researching Denali Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Denali Therapeutics Inc. is a public biotechnology company based in the United States, focused on developing therapies for neurodegenerative diseases. The company is listed under the ticker DNLI and has a market capitalization of approximately $3.67 billion. Denali aims to advance its innovative drug candidates to improve the lives of patients affected by these challenging conditions.
- Ticker
- DNLI:BX
- Asset type
- Stock
- Market cap
- $3.37B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BX
- Currency
- CHF
Denali Therapeutics Inc. DNLI:BX stock context
This page tracks Denali Therapeutics Inc.'s DNLI:BX listing on BX in CHF for CH, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DNLI:BX. DNLI:BX is the stock-level entry point for investors researching Denali Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Denali Therapeutics Inc. is a public biotechnology company based in the United States, focused on developing therapies for neurodegenerative diseases. The company is listed under the ticker DNLI and has a market capitalization of approximately $3.67 billion. Denali aims to advance its innovative drug candidates to improve the lives of patients affected by these challenging conditions.
Latest news from Denali Therapeutics Inc.
Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
August 6, 2026
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026
July 27, 2026
Denali Therapeutics to Give Opening Plenary Address at Alzheimer’s Association International Conference (AAIC) 2026 and Highlight Breakth...
July 9, 2026
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
June 18, 2026
Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson’s Disease
May 21, 2026
Research Denali Therapeutics Inc.
Denali Therapeutics Inc. investor report
Review AI stock analysis and investor report context for DNLI:BX.
Denali Therapeutics Inc. company profile
View the public company page for Denali Therapeutics Inc. on 6ix.
Denali Therapeutics Inc. news
Read company news and market updates connected to Denali Therapeutics Inc..
Denali Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Denali Therapeutics Inc..
Alternate listings
DNLI:NASDAQ
US · USD
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.
A2H9G8:LSX
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.
4DN:GETTEX
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.
A2H9G8:LS
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.
D2NL34:BMFBOVESPA
BR · BRL
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.
4DN:FWB
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.
DNLI:BOATS
US · USD
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.
4DN:DUS
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.
4DN:MUN
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.
4DN:SWB
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.
4DN:TRADEGATE
DE · EUR
Alternate listing for Denali Therapeutics Inc.; the primary context on this page is DNLI:BX.